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Abstract: Recently, it was demonstrated that prolonged hyperinsulinism associated
with hypoglycemia, both in vivo and in vitro, caused covalent glycoinositolpho-
spholipid (GPI) binding to the C termini of both hemoglobin -chains, which re-
sulted in the formation of a novel, hitherto unrecognized, minor hemoglobin fraction
(GPI-Hb) (Niketi} et al., Biochem. Biophys. Res. Commun. 239 (1997) 435). In this
study it was demonstrated that exposure of erythrocyte membranes to insulin causes
the activation of membrane protease as well as that the formation of GPI-Hb paral-
lels its activity. It is suggested that the insulin-activated protease is able to catalyze,
albeit slowly, the transpeptidation, i.e., the replacement of the carboxy-terminal
amino acid(s) residues of the Hb -chains with GPI as an exogenous nucleophile. To
our knowledge the present results show for the first time that insulin stimulates pro-
tease activity in erythrocyte membranes, as well as that insulin-activated protease
may be involved in post-translational GPI binding to proteins.
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INTRODUCTION
Human erythrocytes contain highly specific insulin receptors that have structural
and functional characteristics similar to those of target tissues for the hormone action.1,2
We demonstrated recently that prolonged hyperinsulinism associated with hypogly-
cemia, both in vivo and in vitro, caused covalent glycoinositolphospholipid (GPI) bind-
ing to C termini of both hemoglobin -chains,which resulted in the formation of a novel,
hitherto unrecognised,minorHb fraction (GPI-Hb).3 Free GPI-lipids from human eryth-
rocyte membrane, as opposed to other cell types, are largely cytoplasmatically oriented
and insensitive to insulin-induced hydrolysis.4,5 Binding of insulin to its receptor in tar-
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get cells stimulates a membrane protease,6 and this enzyme was suggested to promote
hydrolysis of GPIs from the GPI-anchors of GPI-proteins.7 We hypothesized that the
molecular mechanism by which insulin induces GPI-transfer to Hb involves activation
of red cell membrane protease, which is able to catalyze transpeptidation, i.e., the re-
placement of the carboxy-terminal amino acid(s) residues of Hb -chainswithGPI as an
exogenous nucleophile.3 The present study was undertaken to test the proposed hypoth-
esis. The results demonstrate that exposure of erythrocyte membranes to insulin causes
the activation of a membrane protease with a trypsin-like specificity, as well as that the
formation of GPI-Hb parallels its activity. It is suggested that the insulin-activated prote-
ase is able to catalyze, albeit slowly, transpeptidation, i.e., the cleavage of peptide bond
between Lys-144 and Trp-145 of the Hb -chain followed with replacement of Trp resi-
due with GPI as an exogenous nucleophile. To our knowledge the present results show
for the first time that insulin stimulates protease activity in erythrocyte membranes and
demonstrates that this proteasemay be involved in the transfer ofGPI-lipid to the protein
in response to insulin binding to the cell.
EXPERIMENTAL
Fresh blood samples (2–5 mL) were taken from normal healthy volunteers and the erythrocytes
were separated as described previously.8 Hemolysis of the erythrocytes and isolation of the membranes
were performed as described by Kundu et al.9 Membrane protein (MP) concentrations were measured
using a modified Lowry procedure.10 The major hemoglobin, the HbAo fraction, was isolated from the
hemolysates by ion exchange chromatography on a Bio-Rex column8 followed by concentration by
ultrafiltration and extensive dialysis against 60 mM sodium phosphate buffer used for the incubation ex-
periments. ATP, BAPNA (N

-benzoyl-DL-arginine p-nitroanilide), BAME (N

-benzoyl-L-arginine
methyl ester) and TLCK (N

-p-tosyl-L-lysine chloromethyl ketone) were all from Sigma. Membranes (5
mg MP/mL) were suspended in 60 mM sodium phosphate buffer pH 7.4 containing 10 M ATP and
graded concentrations of TLCK. Incubation with 1 g/mLof insulin (NOVO, Denmark) in the presence
and absence of HbAo (30mg/mL) was done at 37 ºCwith agitation. Controls without insulin were run in
parallel. After incubation, the aliquots were removed at various times for measurement of the membrane
protease activity and estimation of GPI-Hb. The membranes were sedimented at 22000 g for 15 min at 4
ºC andGPI-Hbwas estimated in the supernatant by applying a locally developedmini columnmethod.11
For the protease activity measurements, the membranes were washed three times in the same buffer (in
which TLCK had been added to the concentration corresponding to that in the incubation mixture) to re-
move insulin and then, resuspended in 1 mL of the same buffer. Protease activity was estimated by ap-
plying the chromogenic substrate BAPNAas described by Cohen.12 The results are given as means  s.d.
for 5 individual experiments performed in duplicate. The differences between the mean values were
evaluated by Student’s t test.
RESULTS AND DISCUSSION
Human erythrocytes contain a number of proteases, both in the cytosolic and
membrane fractions.14–17 To exclude possible effects of cytosolic proteases,14 iso-
lated red cell membranes instead of erythrocytes3,8 were used in this work. To pro-
vide direct evidence for the ability of insulin to activate a human red cell membrane
protease, the effect of the hormone on the hydrolysis of BAPNA, a chromogenic
protease substrate, by red cell membranes was tested. As shown in Table I (A) insu-
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lin induced a significant (ca. 40 %) increase in the hydrolysis of BAPNA compared
to the value measured in controls incubated without insulin. To gain insight into the
specificity of the activated protease, the effect of TLCK, an active-site inhibitor of
trypsin, on the protease activity was examined.6 Table I (A) shows that the insu-
lin-activated protease was selectively inhibited (up to 30 %) by TLCK, whereas the
addition of TLCK did not affect the activity of the membrane protease of red cells
incubated without insulin. Insulin-activation of red cell protease was a rapid pro-
cess: the maximal activities were observed already after an incubation time of 20
min and did not decline upon prolonged incubation, up to 5 h.
TABLE I. Insulin-induced red cell membranes proteolytic activity (A) and GPI-Hb formation (B)
A. Proteolytic acitivty:
Additions
Release of nitroaniline (nmol/min/mg MP)
No insulin + Insulin
None 2.5  0.2 3.6  0.2*
TLCK (30 M 2.5  0.2 3.2  0.3
TLCK (60 M) 2.4  0.1 2.9  0.2*
TLCK (120 M) 2.4  0.2 2.7  0.2*
B. GPI-Hb formation:
Additions
GPI-Hb (% of initially added HbAo)
No insulin + Insulin
None n.d. 2.9  0.2
TLCK (120 M) n.d. 1.6  0.2*
BAME (50 M) n.d. 1.4  0.1*
A. Membranes (5 mg MP/mL) were incubated with and without insulin (1 g/mL) in the presence and
absence of the indicated concentrations of TLCK in 60 mM sodium phosphate buffer pH 7.4 containing
10 MATP for 20 min at 37 ºC. The membranes were sedimented at 22000 g for 15 min at 4 ºC, washed
three times in the same buffer (inwhich TLCKhad been added to the concentration corresponding to that
in the incubation mixture) and then, resuspended in 1 mL of the same buffer. Protease activity was esti-
mated using the chromogenic substrate BAPNA as described in the Experimental.
B. Mixtures of membranes (5 mg MP/mL) and HbAo (30 mg/mL) were incubated with and without
insulin (1 g/mL) in the presence and absence of the indicated concentrations of TLCK and BAME
in 60 mM sodium phosphate buffer pH 7.4 containing 10 MATP for 3 h at 37 ºC. The membranes
were sedimented at 22000 g for 15 min at 4 ºC and the GPI-Hb was estimated in the supernatant as
described in the Experimental procedures.
The results are the means  s.d. of 5 individual experiments performed in duplicate; n.d. – non de-
tectable. Values significantly different from the corresponding control values are indicated *p<0.01.
Cytosolic proteases were found to coelute with minor Hb fractions from the
Bio-Rex column whereas the main HbAo remains devoid of proteolytic activity.13
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To exclude the possible effect of cytosolic proteases on GPI-Hb formation, a purified
HbAo fraction was used in the experiments designed for estimating the GPI-Hb for-
mation. As shown in Table I (B), GPI-Hb (ca. 3 %) was formed upon incubation of
red cell membranes and HbAo in the presence of insulin (but not in its absence). In-
hibition of protease activity with TLCK parallels the decreased yield (by ca. 45 %) of
GPI-Hb (Table I (B)). Addition of BAME, a protease substrate analog,17 resulted
also in a decreased yield (by ca. 50 %) of GPI-Hb. In contrast to insulin activation of
protease, which was a fast process, the formation of GPI-Hb was much slower: the
maximal yield of GPI-Hb was achieved after incubation for 5 h.
In summary, the presented results indicate that insulin activates a novel prote-
ase with trypsin-like specificity in human red cell membranes, which is related to
insulin-activated protease in other cells.6,17 In confirmation of the hypothesis of
other authors,7 we assume that the insulin receptor tyrosine kinase in red cell mem-
branes stimulates the phosphorylation of a specific membrane associated protease,
which activates the enzyme. Hemoglobin is known to interact with lipids from in-
ner membrane surface of red cells.18,19 The GPI transfer to the C termini of Hb
-chains may then be explained by assuming that the phosphate groups of the
GPI-lipids which come in close contact with Hb serve as an affinity label, interact-
ing with the positively charged groups at the 2,3-BPG binding site in the Hb mole-
cule permitting the ethanolamine fromGPI to come in close contact with the C-ter-
minal part of the  polypeptide chain of the Hb molecule. In the lipid environment
of the red-cell membrane, the activated protease is able to catalyze, albeit slowly,
the transpeptidation, i.e., the replacement of the carboxy-terminal amino acid(s)
residues with GPI as an exogenous nucleophile. The candidate for the cleavage site
is the peptide bond between the residues Lys-144 and Trp-145 in the -chain of Hb,
followed by GPI binding to the carboxy terminal of the Lys-144 residue and con-
comitant release of the C-terminal Trp-His dipeptide. Detailed studies of the insu-
lin-activated red cell protease and the effects it produces on red cell proteins are
currently under progress in our laboratory.
The mechanism of GPI addition to Hb described in this work may be relevant
to other proteins as well. Thus, GPI addition to Hb was found to parallel its addi-
tion to some of the erythrocyte membrane proteins,20 and insulin-induced hydroly-
sis of GPI-anchored proteins from the cell surface was found to precede their re-
covery upon prolonged insulin exposure.21 Activation of protease was found to be
associated with the activation of erythrocyte membrane phospholipase C (V.
Niketi}, unpublished observation). Human erythrocytes, which represent an ex-
tremely useful and easily accessible cellular model for the study of a variety of pro-
teins, seem to be well suited also for studying the effects and the processes in-
volved in cross-talk between GPIs and insulin.22,23 The results described in the
present paper may bear relevance to studies of physiological disorders that are
characterized by hyperinsulinism, such as cases of diabetes and hypoglycemia.
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I Z V O D
KOVALENTNO VEZIVAWE GLIKOINOZITOLFOSFOLIPIDA (GPI) ZA
HEMOGLOBIN POD DEJSTVOM INSULINA PRA]ENO JE AKTIVIRAWEM
PROTEAZE IZ MEMBRANE ERITROCITA
DRAGANA STANI]1, MILAN NIKOLI]2 i VESNA NIKETI]2
1IHTM – Centar za hemiju, Wego{eva 12, 11001 Beograd i 2Hemijski fakultet, Studentski trg 12-16,
p.pr. 158, 11001 Beograd
U na{im ranijim radovima pokazano je da u uslovima hiperinsulinizma i hipo-
glikemije, in vivo i in vitro, dolazi do kovalentnog vezivawa glikoinozitolfosfoli-
pida (GPI) za karboksilne krajeve oba -niza molekula hemoglobina (Hb), {to se ma-
nifestuje nastajawem nove, do tada nepoznate, mawe frakcije hemoglobina (GPI-Hb)
(Niketi} et al., Biochem. Biophys. Res. Commun. 239 (1997) 435). U ovom radu je pokazano da
vezivawe insulina za membrane eritrocita izaziva aktivirawe membranske pro-
teaze, te da je nastajawe GPI-Hb u korelaciji sa proteaznom aktivno{}u. Pretpostav-
qeno je da proteaza aktivirana insulinom mo`e, mada sporo, da katalizuje reakciju
transpeptidacije, tj. zamenu aminokiselinskih ostataka sa karboksilnog kraja -ni-
zova molekula Hb sa GPI-lipidom kao egzogenim nukleofilom. Prema na{em saznawu
opisani rezultati prvi puta pokazuju da insulin stimuli{e proteaznu aktivnost u
eritrocitima, te da je ova aktivnost povezana sa post-translacionim vezivawem
GPI-lipida za proteine.
(Primqeno 17. septembra 2003)
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